Worldwide Cholera Vaccines Industry to 2027 – Featuring Merck & Co, Pfizer, PharmaChoice Canada and Sanofi Among Others – ResearchAndMarkets.com

Worldwide Cholera Vaccines Industry to 2027 – Featuring Merck & Co, Pfizer, PharmaChoice Canada and Sanofi Among Others – ResearchAndMarkets.com




Worldwide Cholera Vaccines Industry to 2027 – Featuring Merck & Co, Pfizer, PharmaChoice Canada and Sanofi Among Others – ResearchAndMarkets.com

DUBLIN–(BUSINESS WIRE)–The “Cholera Vaccines Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2022-2027” report has been added to ResearchAndMarkets.com’s offering.

The global cholera vaccines market reached a value of US$ 4.36 million in 2021. Looking forward, the market is projected to reach a value of US$ 8.63 million by 2027, exhibiting a CAGR of 11.70% during 2022-2027.

Companies Mentioned

  • Astellas Pharma Inc.
  • Celldex Therapeutics Inc. (Avant Immunotherapeutics Inc.)
  • Emergent BioSolutions Inc.
  • Eubiologics Co. Ltd.
  • Johnson & Johnson
  • Merck & Co. Inc
  • Pfizer Inc.
  • PharmaChoice Canada Inc
  • Sanofi S.A.
  • Takeda Pharmaceutical Company Limited
  • Valneva SE

Keeping in mind the uncertainties of COVID-19, the analyst is continuously tracking and evaluating the direct as well as the indirect influence of the pandemic. These insights are included in the report as a major market contributor.

Cholera is an intestinal disease caused by bacterial infections that spread through contaminated food and water. It leads to severe diarrhea, dehydration, abdominal pain, fever, rapid heart rate, loss of skin elasticity, low blood pressure, muscle cramps, and dry mucous membranes, such as the inside of the mouth, throat, nose, and eyelids. It is presently a global threat to public health, which can be prevented through the vaccine. The cholera vaccine exposes a small dose of live cholera bacteria in the body that helps develop immunity against the disease. It can be given orally or injected intradermally or intramuscularly in the body.

The growing prevalence of cholera on account of poor hygiene and sanitation represents one of the major factors driving the market. In addition, there is a rise in the use of contaminated water for agriculture and olericulture across the globe. This, along with the increasing consumption of street and fast food due to the hectic lifestyles of individuals, is propelling the growth of the market.

Moreover, there is a considerable rise in water pollution on account of sewage and factory wastes getting discharged into lakes and rivers. As a result, people are consuming contaminated seafood worldwide, which, in turn, is resulting in the spread of cholera. Additionally, rising awareness about cholera through initiatives of non-governmental organizations (NGOs), along with numerous immunization programs introduced by governments of several countries to reduce vaccine-preventable diseases, is positively influencing the market. Furthermore, key market players are extensively investing in research and development (R&D) activities to provide more efficient and cost-effective cholera vaccines, which is projected to propel the growth of the market.

Key Questions Answered in This Report

  • How has the global cholera vaccines market performed so far and how will it perform in the coming years?
  • What has been the impact of COVID-19 on the global cholera vaccines market?
  • What are the key regional markets?
  • What is the breakup of the market based on the vaccine type?
  • What is the breakup of the market based on the product?
  • What is the breakup of the market based on the End-user?
  • What are the various stages in the value chain of the industry?
  • What are the key driving factors and challenges in the industry?
  • What is the structure of the global cholera vaccines market and who are the key players?
  • What is the degree of competition in the industry?

Key Topics Covered:

1 Preface

2 Scope and Methodology

3 Executive Summary

4 Introduction

4.1 Overview

4.2 Key Industry Trends

5 Global Cholera Vaccines Market

5.1 Market Overview

5.2 Market Performance

5.3 Impact of COVID-19

5.4 Market Forecast

6 Market Breakup by Vaccine Type

7 Market Breakup by Product

8 Market Breakup by End User

9 Market Breakup by Region

10 SWOT Analysis

11 Value Chain Analysis

12 Porters Five Forces Analysis

13 Price Analysis

14 Competitive Landscape

14.1 Market Structure

14.2 Key Players

14.3 Profiles of Key Players

For more information about this report visit https://www.researchandmarkets.com/r/j2xw84

Contacts

ResearchAndMarkets.com

Laura Wood, Senior Press Manager

press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470

For U.S./CAN Toll Free Call 1-800-526-8630

For GMT Office Hours Call +353-1-416-8900